[American Academy of Neurology, Philadelphia, 26 April-3 May, 2014]

Related Experiment Video

Updated: Jul 29, 2026

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

9.9K

F Durif1, I Sibon1, B de Toffol1

  • 1Hôpital de la Salpêtrière, bâtiment Babinski, consultation de pathologie neuro-musculaire, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Revue Neurologique
|June 2, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure
04:18

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

2.3K
Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish
06:49

Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish

Published on: September 30, 2025

1.1K

Related Experiment Videos

Last Updated: Jul 29, 2026

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

9.9K
Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure
04:18

Author Spotlight: A Novel Approach to Cerebral Ischemia Modeling – Enhancing Reperfusion and Simplifying Procedure

Published on: May 31, 2024

2.3K
Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish
06:49

Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish

Published on: September 30, 2025

1.1K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Articles linked to this work by shared authors, journal, and citation graph.

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026

Retrospective, descriptive study of acute myelitis in French Guyana.

Revue neurologique·2025

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024

Epilepsy and psychosis.

Revue neurologique·2024

Medical demography at stroke centers: Current situation in France.

Revue neurologique·2023

Ciguatera poisoning associated with cytotoxic lesions of the corpus callosum syndrome (CLOCCS): Clinical case description and literature review.

Revue neurologique·2026

Evaluation of the management of patients with suspected epileptic seizures in emergency departments: The EPI-Lepsie study.

Revue neurologique·2026

Prevalence and prognostic significance of intracranial lesions assessed with MRI in infective endocarditis patients: Data from the Vesuve study.

Revue neurologique·2026

Nonlinear absorber device to treat essential tremor: The TREM-AB open-label pilot study.

Revue neurologique·2026

Why did residents choose neurology? Motivational profile and influence of demographic and career factors.

Revue neurologique·2026

Tremor or myoclonus? A practical clinical approach to distinguishing two common hyperkinetic movement disorders.

Revue neurologique·2026

The Research Domain Criteria (RDoC) and the Five Aggregates (skandha-s) of the Early Buddhism: Parallels and Differences on Understanding of Human Mind.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2026

Plasma β-synuclein associates with hippocampal synaptic density measured with [11C]UCB-J PET and plasma tau markers in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Role of Substance P in physiological and pathological states of the pancreas.

Neuroendocrinology·2026

Emotional Eating Beyond Obesity: A Transdiagnostic Conceptual Analysis of Phenotyping, Measurement, and Priorities for Clinical Validation.

Nutrients·2026

The Influence of Neurotic Disorders and Neurobiological Basis on Eating Behavior in a 21-Year-Old Patient: A Case Study-Diagnostic Difficulties: Is It PANDAS/PANS in Relation to an Elevated ASO Level and the Diagnosis of OCD?

Journal of clinical medicine·2026

Selective Dopamine Transporter Inhibitor CE-123 Modulates Region-Specific Intestinal Mucosal and Immune Responses Following Fear Conditioning and Extinction in Adolescent Female Rats.

Biomedicines·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us